Perry RJ, Samuel VT, Petersen KF, Shulman GI (2014) The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
10.1097/MOH.0000000000000574 12 De MariaR.TestaU.LuchettiL.ZeunerA.StassiG.PelosiE.et al (1999)
Experts say patients taking GLP-1-based medications should monitor for mood changes and report symptoms such as: New or worsening depression Anxiety or emotional changes Suicidal thoughts More research is needed to determine whether these drugs directly affect mood or whether changes are related to factors such as rapid weight loss, hormonal changes or other metabolic effects
The authors suggest it may have future potential not only in skin and wound care, but also in supporting healthy aging, managing chronic inflammatory and degenerative conditions, and possibly as an adjunct approach in diseases such as COPD and cancer
No claims of therapeutic, medical, or physiological benefit are made or implied